(R)-1-phenyl-2-propynylamine | 226699-14-5

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: (R)-1-phenyl-2-propynylamine
• 英文别名: (S)-1-phenyl-2-propinylamine；(R)-3-amino-3-phenylprop-1-yne；(R)-1-phenylprop-2-yn-1-amine；(1R)-1-phenylprop-2-yn-1-amine
• CAS: 226699-14-5
• 化学式: C₉H₉N
• 分子量: 131.177
• InChiKey: WTZFFHKYDKHUSG-SECBINFHSA-N

物化性质

• 沸点：
  209.8±20.0 °C(Predicted)
• 密度：
  1.033±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  (R)-1-phenyl-2-propynylamine 在 Lindlar's catalyst 吡啶 、 四氧化锇 、 氢气 、 N-甲基吗啉氧化物 作用下， 以 四氢呋喃 、 二氯甲烷 、 水 、 乙二胺 、 N,N-二甲基甲酰胺 为溶剂， 20.0 ℃ 、101.33 kPa 条件下， 反应 50.0h， 生成 3(S)-(-)-(N-Benzoylamino)-2(S)-hydroxy-3-phenylpropanol
  参考文献：
  名称：

  1-芳基-2- propenylamines对映选择性合成：一种新的方法对紫杉醇的立体选择性合成®侧链

  摘要：

  通过脂肪酶催化的相应外消旋体的拆分，制备了各种高对映体纯度的取代的1-芳基-2-丙烯基胺。（- [R）-1-苯基-2-丙烯基胺进一步合成为（2 - [R，3小号）-3-苯甲酰氨基-2-羟基-3-苯基丙酸甲基酯，紫杉醇的侧链®。

  DOI：

  10.1016/j.tetasy.2004.01.035
• 作为产物：
  描述：

  (R)-N-(α-phenylpropargyl)acetamide 在 盐酸 作用下， 以 水 为溶剂， 反应 6.0h， 以60%的产率得到(R)-1-phenyl-2-propynylamine
  参考文献：
  名称：

  Resolution of (±)-1-Aryl-2-propynylamines via Acyltransfer Catalyzed by Candida antarctica Lipase

  摘要：

  DOI：

  10.1021/jo982513i

文献信息

• Homo- and heterodimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part I: Synthesis
  作者：Leonardo Manzoni、Laura Belvisi、Aldo Bianchi、Annalisa Conti、Carmelo Drago、Marilenia de Matteo、Luca Ferrante、Eloise Mastrangelo、Paola Perego、Donatella Potenza、Carlo Scolastico、Federica Servida、Gabriele Timpano、Francesca Vasile、Vincenzo Rizzo、Pierfausto Seneci

  DOI：10.1016/j.bmc.2012.09.020

  日期：2012.11

  Novel pro-apoptotic, homo-and heterodimeric Smac mimetics/IAPs inhibitors based on the N-AVPI-like 4-substituted 1-aza-2-oxobicyclo[5.3.0]decane scaffold were prepared from monomeric structures connected through a head-head (8), tail-tail (9) or head-tail (10) linker. The selection of appropriate decorating functions for the scaffolds, and of rigid and flexible linkers connecting them, is described. The synthesis, purification and analytical characterization of each prepared dimer 8-10 is thoroughly described. (C) 2012 Elsevier Ltd. All rights reserved.
• Design, Synthesis, and Characterization of a Potent, Nonpeptide, Cell-Permeable, Bivalent Smac Mimetic That Concurrently Targets Both the BIR2 and BIR3 Domains in XIAP
  作者：Haiying Sun、Zaneta Nikolovska-Coleska、Jianfeng Lu、Jennifer L. Meagher、Chao-Yie Yang、Su Qiu、York Tomita、Yumi Ueda、Sheng Jiang、Krzysztof Krajewski、Peter P. Roller、Jeanne A. Stuckey、Shaomeng Wang

  DOI：10.1021/ja074725f

  日期：2007.12.1

  XIAP is a central apoptosis regulator that inhibits apoptosis by binding to and inhibiting the effectors caspase-3/-7 and an initiator caspase-9 through its BIR2 and BIR3 domains, respectively. Smac protein in its dimeric form effectively antagonizes XIAP by concurrently, targeting both its BIR2 and BIR3 domains. We report the design, synthesis, and characterization of a nonpeptide, cell-permeable, bivalent small-molecule (SM-164) which mimics Smac protein for targeting XIAP. Our study shows that SM-164 binds to XIAP containing both BIR domains with an IC50 value of 1.39 nM, being 300 and 7000 times more potent than its monovalent counterparts and the natural Smac AVPI peptide, respectively. SM-164 concurrently interacts with both BIR domains in XIAP and functions as an ultrapotent antagonist of XIAP in both cell-free functional and cell-based assays. SM-164 targets cellular XIAP and effectively induces apoptosis at concentrations as low as 1 nM in the HL-60 leukemia cell line. The potency of bivalent SM-164 in binding, functional, and cellular assays is 2-3 orders of magnitude higher than its corresponding monovalent Smac mimetics.
• Stereoselective synthesis of α-aryl-2-benzofuranmethanamines and α-aryl-1H-indole-2-methanamines through palladium-mediated annulation of chiral α-arylpropargylamines
  作者：Flavia Messina、Maurizio Botta、Federico Corelli、Claudio Villani

  DOI：10.1016/s0957-4166(00)00131-2

  日期：2000.5

  The title compounds, valuable chiral synthons for the synthesis of biologically active compounds, have been prepared in good yield and with high stereoselectivity through palladium-catalyzed heteroannulation of 2-iodophenol or 2-iodo-N-mesylaniline with enantiomerically pure or enriched alpha-arylpropargylamines. (C) 2000 Elsevier Science Ltd. All rights reserved.
• Chiral Azole Derivatives. 4.¹ Enantiomers of Bifonazole and Related Antifungal Agents:  Synthesis, Configuration Assignment, and Biological Evaluation
  作者：Maurizio Botta、Federico Corelli、Francesco Gasparrini、Flavia Messina、Claudia Mugnaini

  DOI：10.1021/jo991937p

  日期：2000.7.1
• A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment
  作者：Qian Cai、Haiying Sun、Yuefeng Peng、Jianfeng Lu、Zaneta Nikolovska-Coleska、Donna McEachern、Liu Liu、Su Qiu、Chao-Yie Yang、Rebecca Miller、Han Yi、Tao Zhang、Duxin Sun、Sanmao Kang、Ming Guo、Lance Leopold、Dajun Yang、Shaomeng Wang

  DOI：10.1021/jm101505d

  日期：2011.4.28

  We report the discovery and characterization of SM-406 (compound 2), a potent and orally bioavailable Smac mimetic and an antagonist of the inhibitor of apoptosis proteins (IAPs). This compound binds to XIAP, cIAP1, and cIAP2 proteins with K(i) of 66.4, 1.9, and 5.1 nM, respectively. Compound 2 effectively antagonizes XIAP BIR3 protein in a cell-free functional assay, induces rapid degradation of cellular cIAP1 protein, and inhibits cancer cell growth in various human cancer cell lines. It has good oral bioavailability in mice, rats, non-human primates, and dogs, is highly effective in induction of apoptosis in xenograft tumors, and is capable of complete inhibition of tumor growth. Compound 2 is currently in phase I clinical trials for the treatment of human cancer.